In addition, PCSK9 inhibitors have also been found to increase the effects of ICI therapies, improve the host immune response against cancer cells, induce cancer cell apoptosis, and may have a role in the management of complications such as sepsis and dyslipidemia, which can also be seen in cancer patients and survivors
Other Medications: Interaction Risks GLP-1 receptor agonists, like Semaglutide , Tirzepatide , and Liraglutide , are widely used for managing diabetes and weight loss
Check Your Coverage A lipase inhibitor that blocks fat absorption in the gut
It does not eliminate risk
doi: 10.1023/A:1022073819618 65 GaultVParkerJHarriottPFlattPRO'HarteFP
- Dosage: Start with a low dose of 250 mcg to 500 mcg per day to assess tolerance, then increase to 1 mg per day